Although its precise role in PC remains unclear, it is known that the serum levels of ADA in patients with pancreatic diseases differ significantly from those in healthy individuals (83), particularly in patients with PC, making it a potential area for further investigation. The gene discussed is ADA; the disease is pachyonychia congenita.